ECSP982794A - COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY - Google Patents

COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY

Info

Publication number
ECSP982794A
ECSP982794A ECSP982794A ECSP982794A EC SP982794 A ECSP982794 A EC SP982794A EC SP982794 A ECSP982794 A EC SP982794A EC SP982794 A ECSP982794 A EC SP982794A
Authority
EC
Ecuador
Prior art keywords
composition
molecular dispersion
increased bioavailability
molecular
dispersion
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Surendra A Sangekar
Ping I Lee
Amin A Nomeir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982794 priority Critical patent/ECSP982794A/en
Publication of ECSP982794A publication Critical patent/ECSP982794A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición para dispersión molecular. La dispersión molecular comprende a un compuesto de la fórmula: (gráfico), molecularmente disperso en una matriz polimérica. También se describen las formas de dosificación sólidas por ejemplo, tabletas y cápsulas que contienen a estas dispersiones moleculares.A composition for molecular dispersion is described. The molecular dispersion comprises a compound of the formula: (graph), molecularly dispersed in a polymer matrix. Solid dosage forms are also described eg tablets and capsules containing these molecular dispersions.

ECSP982794 1998-12-17 1998-12-17 COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY ECSP982794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982794 ECSP982794A (en) 1998-12-17 1998-12-17 COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982794 ECSP982794A (en) 1998-12-17 1998-12-17 COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY

Publications (1)

Publication Number Publication Date
ECSP982794A true ECSP982794A (en) 1999-06-01

Family

ID=42043712

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982794 ECSP982794A (en) 1998-12-17 1998-12-17 COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY

Country Status (1)

Country Link
EC (1) ECSP982794A (en)

Similar Documents

Publication Publication Date Title
BR0009486B1 (en) compound comprising an amide, pharmaceutical composition comprising such compound, its use and process for the preparation thereof.
BR0109198A (en) Plaster with ultraviolet filter
UY27346A1 (en) PHARMACCUTIC COMPOSITIONS CONTAINING POLYMER AND FRRMACO SETS.
PA8513601A1 (en) PHARMACEUTICAL COMPOSITIONS OF GLUCOGENOPHOSPHORILASE INHIBITORS
BR9912980B1 (en) ORALLY MANAGEMENT PHARMACEUTICAL COMPOSITION, MASKING TABLE CONTAINING THE SAME AND USING THE SAME
ITRM940621A0 (en) "STABILIZED PHARMACEUTICAL COMPOSITION, RELATED SOLVENT AND PREPARATION PROCEDURE"
ATE241612T1 (en) 2-(IMINOETHYL)-AMINOPHENYL - DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
TR199800743A3 (en) Continuous release polymer mixture matrix for pharmaceutical application.
BR9807814B1 (en) pyrazine compound, pharmaceutical composition, use of a compound, and process for the preparation of a compound.
NO953767D0 (en) Crosslinked amylose as a binder / dissolving agent in tablets
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
ES2184452T3 (en) PHARMACEUTICAL PREPARATION CONTAINING SODIUM LEVOTIROXIN.
BR9906070A (en) Substituted benzamides
CO4970793A1 (en) COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY
PE20001326A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING CEFUROXIMA-AXETILE, POLYMER AND / OR ADSORBENT
KR920002151A (en) Inflammatory Disease Treatment with 15-Keto-Prostaglandin Compounds
BR0109802A (en) Pharmaceutical preparations and their manufacture
BR0005444A (en) Bleaching process for lignocellulosic materials
TR199802351T2 (en) Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.
ES2171018T3 (en) USE OF IMMUNOMODULATING AGENTS.
AR023699A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN STABILIZER AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
CA2317954A1 (en) Device for coating granules to be administered orally
ATE237316T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IBUPROFEN AND DOMPERIDONE
ECSP982794A (en) COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY